PL354749A1 - Kompleks wapniowy pochodnych etylenodiaminy zawierających fosfor - Google Patents

Kompleks wapniowy pochodnych etylenodiaminy zawierających fosfor

Info

Publication number
PL354749A1
PL354749A1 PL00354749A PL35474900A PL354749A1 PL 354749 A1 PL354749 A1 PL 354749A1 PL 00354749 A PL00354749 A PL 00354749A PL 35474900 A PL35474900 A PL 35474900A PL 354749 A1 PL354749 A1 PL 354749A1
Authority
PL
Poland
Prior art keywords
kappa
calcium complex
phosphorus containing
containing ethylenediamine
ethylenediamine derivatives
Prior art date
Application number
PL00354749A
Other languages
English (en)
Inventor
Johannes Platzek
Ulrich Niedballa
Gunter Michl
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7922563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL354749(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1999144893 external-priority patent/DE19944893C2/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL354749A1 publication Critical patent/PL354749A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)
PL00354749A 1999-09-09 2000-09-06 Kompleks wapniowy pochodnych etylenodiaminy zawierających fosfor PL354749A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999144893 DE19944893C2 (de) 1999-09-09 1999-09-09 Calcium-Komplex von [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-. kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6, .kappa.N9,.kappa.O11]1-oxidato(6-)]-, hexahydrogen, dessen Salze und diese Komplexe enthaltende pharmazeutische Mittel
PCT/EP2000/008694 WO2001018011A1 (en) 1999-09-09 2000-09-06 Calcium complex of phosphorus containing ethylenediamine derivatives

Publications (1)

Publication Number Publication Date
PL354749A1 true PL354749A1 (pl) 2004-02-23

Family

ID=7922563

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00354749A PL354749A1 (pl) 1999-09-09 2000-09-06 Kompleks wapniowy pochodnych etylenodiaminy zawierających fosfor

Country Status (30)

Country Link
EP (1) EP1210353B1 (pl)
JP (1) JP2003508537A (pl)
KR (1) KR100650090B1 (pl)
CN (1) CN100341883C (pl)
AT (1) ATE245159T1 (pl)
AU (1) AU783982B2 (pl)
BG (1) BG65280B1 (pl)
BR (1) BR0013871A (pl)
CA (1) CA2380766C (pl)
CZ (1) CZ2002834A3 (pl)
DE (2) DE19964224B4 (pl)
DK (1) DK1210353T3 (pl)
EE (1) EE05106B1 (pl)
ES (1) ES2202178T3 (pl)
HK (1) HK1050202A1 (pl)
HR (1) HRP20020302B1 (pl)
HU (1) HUP0202873A3 (pl)
IL (1) IL148563A (pl)
MX (1) MXPA02001583A (pl)
NO (1) NO20021167L (pl)
NZ (1) NZ517708A (pl)
PL (1) PL354749A1 (pl)
PT (1) PT1210353E (pl)
RS (1) RS50125B (pl)
RU (1) RU2247727C2 (pl)
SK (1) SK3242002A3 (pl)
TW (1) TWI263641B (pl)
UA (1) UA74165C2 (pl)
WO (1) WO2001018011A1 (pl)
ZA (1) ZA200202742B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201514188A (zh) * 2013-03-13 2015-04-16 Lantheus Medical Imaging Inc 製備釓磷維塞三鈉單水合物之方法
CN114845990A (zh) 2019-12-20 2022-08-02 伯拉考成像股份公司 钙bopta配合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
TW319763B (pl) * 1995-02-01 1997-11-11 Epix Medical Inc
US5919967A (en) * 1997-04-11 1999-07-06 Epix Medical, Inc. Process for synthesizing phosphodiesters

Also Published As

Publication number Publication date
HRP20020302A2 (en) 2004-02-29
DE60003931D1 (de) 2003-08-21
TWI263641B (en) 2006-10-11
HRP20020302B1 (en) 2005-08-31
RS50125B (sr) 2009-03-25
DE60003931T2 (de) 2004-05-27
CZ2002834A3 (cs) 2002-07-17
HK1050202A1 (en) 2003-06-13
RU2247727C2 (ru) 2005-03-10
BG65280B1 (bg) 2007-11-30
UA74165C2 (uk) 2005-11-15
ATE245159T1 (de) 2003-08-15
ES2202178T3 (es) 2004-04-01
CN100341883C (zh) 2007-10-10
MXPA02001583A (es) 2004-04-05
ZA200202742B (en) 2003-09-23
EP1210353A1 (en) 2002-06-05
YU16102A (sh) 2005-06-10
WO2001018011A1 (en) 2001-03-15
HUP0202873A3 (en) 2003-12-29
NZ517708A (en) 2003-10-31
KR100650090B1 (ko) 2006-11-27
EE200200090A (et) 2003-04-15
NO20021167D0 (no) 2002-03-08
BG106488A (en) 2002-10-31
IL148563A (en) 2005-12-18
PT1210353E (pt) 2003-11-28
DE19964224B4 (de) 2005-09-01
IL148563A0 (en) 2002-09-12
AU783982B2 (en) 2006-01-12
EE05106B1 (et) 2008-12-15
AU7774900A (en) 2001-04-10
JP2003508537A (ja) 2003-03-04
SK3242002A3 (en) 2002-10-08
DE19964224A1 (de) 2001-06-28
CA2380766A1 (en) 2001-03-15
EP1210353B1 (en) 2003-07-16
DK1210353T3 (da) 2003-10-27
CA2380766C (en) 2008-11-25
BR0013871A (pt) 2002-05-21
HUP0202873A2 (hu) 2002-12-28
WO2001018011A9 (en) 2002-09-06
NO20021167L (no) 2002-03-08
KR20020025256A (ko) 2002-04-03
CN1373765A (zh) 2002-10-09

Similar Documents

Publication Publication Date Title
TNSN98203A1 (fr) Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
AU4925199A (en) Quinolin-2-one derivatives useful as anticancer agents
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
TNSN99162A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
HUT65192A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino benzazepine derivatives and pharmaceutical preparations containing
TNSN97023A1 (fr) Derives de triazole utiles en therapeutique, procedes pour leur preparation et compositions les contenant.
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
HU9601846D0 (en) Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.
AU6797298A (en) Halo-alkoxycarbonyl prodrugs
HK1050202A1 (en) Calcium complex of phosphorus containing ethylenediamine derivatives
IL154755A0 (en) Antitumor theraphy comprising distamycin derivatives
IL143751A0 (en) Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
IL147890A0 (en) Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives
AP2001002369A0 (en) Pharmaceutical complex.
FR2450840A1 (fr) Complexes orthophosphates de cis-diammineplatine(ii) utiles comme medicaments et compositions pharmaceutiques les contenant
WO1992019573A3 (en) Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
TR200000753T2 (tr) Mukabil antifungal ajan için prodrog olarak tetrahidrofuran fosfat ve hidroksi esterleri.
UA40656C2 (uk) Засіб "феррофол" для лікування залізодефіцитної анемії
MX9709001A (es) Composicion farmaceutica preparada por la adicion de un vehiculo saborizante para un medicamento.
TNSN91040A1 (fr) Derives de benzofuranne
UA30361A (uk) Спосіб лікування глікозидної інтоксикації